C3.ai (NYSE:AI) Stock Price Up 1.6% - Here's Why

Key Points

• C3.ai's stock price rose by 1.6% during mid-day trading, reaching $15.88, although trading volume decreased by 48% compared to average daily volume.
• Recent analyst ratings have been mixed, with Morgan Stanley raising its price target from $20.00 to $22.00 while others set lower targets, resulting in a consensus rating of "Reduce" for the stock.
• In its last earnings report, C3.ai posted a significant loss of ($0.86) per share, missing estimates and showing a 19.4% revenue decline year-over-year.

C3.ai, Inc. (NYSE:AI - Get Free Report)'s share price was up 1.6% during mid-day trading on Monday . The stock traded as high as $16.07 and last traded at $15.88. Approximately 3,245,926 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 6,293,180 shares. The stock had previously closed at $15.62.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on AI shares. Morgan Stanley increased their price target on C3.ai from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Thursday, May 29th. Northland Capmk downgraded shares of C3.ai from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 11th. KeyCorp dropped their target price on C3.ai from $18.00 to $10.00 and set an "underweight" rating for the company in a research report on Thursday. JPMorgan Chase & Co. reduced their target price on shares of C3.ai from $27.00 to $23.00 and set an "underweight" rating for the company in a research report on Thursday, May 29th. Finally, Canaccord Genuity Group decreased their target price on C3.ai from $28.00 to $16.00 and set a "hold" rating for the company in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, C3.ai currently has a consensus rating of "Reduce" and a consensus price target of $23.00.

C3.ai Stock Performance

The firm's 50-day simple moving average is $22.24 and its 200 day simple moving average is $22.58. The stock has a market capitalization of $2.11 billion, a P/E ratio of -6.03 and a beta of 1.96.

C3.ai (NYSE:AI - Get Free Report) last posted its earnings results on Wednesday, September 3rd. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.65). The firm had revenue of $70.26 million during the quarter, compared to the consensus estimate of $104.02 million. C3.ai had a negative return on equity of 40.06% and a negative net margin of 92.08%.The business's revenue was down 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.05) EPS. C3.ai has set its Q2 2026 guidance at EPS. As a group, research analysts expect that C3.ai, Inc. will post -2.44 earnings per share for the current fiscal year.

Insider Transactions at C3.ai

In related news, CFO Hitesh Lath sold 17,689 shares of C3.ai stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $24.96, for a total value of $441,517.44. Following the completion of the transaction, the chief financial officer owned 166,218 shares in the company, valued at approximately $4,148,801.28. The trade was a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Merel Witteveen sold 5,485 shares of the stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $23.95, for a total value of $131,365.75. Following the completion of the sale, the vice president directly owned 13,740 shares of the company's stock, valued at $329,073. The trade was a 28.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,161,058 shares of company stock valued at $50,480,751. 26.50% of the stock is owned by insiders.

Hedge Funds Weigh In On C3.ai

A number of institutional investors and hedge funds have recently modified their holdings of AI. Zweig DiMenna Associates LLC acquired a new position in shares of C3.ai in the 1st quarter worth approximately $274,000. Liontrust Investment Partners LLP boosted its position in C3.ai by 203.2% in the first quarter. Liontrust Investment Partners LLP now owns 144,288 shares of the company's stock valued at $3,037,000 after buying an additional 96,695 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of C3.ai in the first quarter valued at approximately $668,000. Banque Cantonale Vaudoise bought a new stake in shares of C3.ai in the first quarter valued at about $390,000. Finally, GAMMA Investing LLC lifted its stake in shares of C3.ai by 4,846.5% in the first quarter. GAMMA Investing LLC now owns 12,020 shares of the company's stock worth $253,000 after acquiring an additional 11,777 shares during the period. 38.96% of the stock is currently owned by hedge funds and other institutional investors.

About C3.ai

C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.